IRIS UniCatt

De Cristofaro, Raimondo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.038
AS - Asia 5.459
EU - Europa 4.966
SA - Sud America 1.038
Continente sconosciuto - Info sul continente non disponibili 193
AF - Africa 145
OC - Oceania 17
Totale 18.856
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.832
SG - Singapore 2.443
DE - Germania 1.506
CN - Cina 1.280
BR - Brasile 852
SE - Svezia 815
IT - Italia 585
VN - Vietnam 516
UA - Ucraina 465
FR - Francia 420
GB - Regno Unito 244
IE - Irlanda 234
IN - India 228
FI - Finlandia 181
JP - Giappone 168
ID - Indonesia 164
PL - Polonia 157
BD - Bangladesh 155
RU - Federazione Russa 130
HK - Hong Kong 126
CA - Canada 105
AR - Argentina 79
TR - Turchia 74
IQ - Iraq 63
MX - Messico 54
NL - Olanda 49
ZA - Sudafrica 47
KR - Corea 38
BE - Belgio 26
EC - Ecuador 26
ES - Italia 23
PK - Pakistan 23
IR - Iran 21
SA - Arabia Saudita 21
AT - Austria 20
CO - Colombia 19
UZ - Uzbekistan 19
MA - Marocco 17
VE - Venezuela 17
AU - Australia 16
CL - Cile 15
KE - Kenya 15
EG - Egitto 14
LT - Lituania 14
RO - Romania 14
CI - Costa d'Avorio 13
PH - Filippine 13
TN - Tunisia 13
CZ - Repubblica Ceca 12
JM - Giamaica 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 10
MY - Malesia 10
UY - Uruguay 10
IL - Israele 9
JO - Giordania 9
NP - Nepal 9
CR - Costa Rica 8
HN - Honduras 8
AL - Albania 7
CH - Svizzera 7
LV - Lettonia 7
MK - Macedonia 7
OM - Oman 7
PT - Portogallo 7
HU - Ungheria 6
KZ - Kazakistan 6
SN - Senegal 6
BH - Bahrain 5
KG - Kirghizistan 5
KW - Kuwait 5
NO - Norvegia 5
PE - Perù 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
EU - Europa 4
GR - Grecia 4
PS - Palestinian Territory 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BG - Bulgaria 3
HR - Croazia 3
LU - Lussemburgo 3
PA - Panama 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CY - Cipro 2
DK - Danimarca 2
LK - Sri Lanka 2
MM - Myanmar 2
PR - Porto Rico 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 18.649
Salva come PNG Salva come JPEG
Città #
Singapore 1.255
Ashburn 873
San Jose 763
Chandler 657
Jacksonville 250
Beijing 245
Dublin 225
San Mateo 212
Los Angeles 161
Nanjing 161
Ho Chi Minh City 160
Tokyo 152
New York 150
Jakarta 146
Lauterbourg 146
Wilmington 145
Warsaw 133
Hefei 130
Hanoi 127
Milan 122
Ann Arbor 112
St Louis 108
Hong Kong 105
Boston 100
Woodbridge 99
Chicago 95
Munich 89
Dearborn 88
Houston 87
Moscow 81
Frankfurt am Main 80
Fairfield 77
Seattle 72
Lawrence 71
Pune 71
Redwood City 71
São Paulo 69
Santa Clara 67
Dallas 66
Nürnberg 65
Helsinki 57
Princeton 55
Rome 55
Cattolica 53
Nanchang 52
Council Bluffs 50
Buffalo 47
Marseille 46
Redmond 45
London 42
The Dalles 40
Boardman 37
Izmir 36
Rio de Janeiro 35
Phoenix 33
Seoul 33
University Park 33
Bremen 32
Kent 32
Orem 32
Hangzhou 31
Da Nang 29
Augusta 28
Paris 28
Kunming 27
Tianjin 27
Nuremberg 26
Mexico City 25
Mountain View 25
Baghdad 24
Turku 24
Atlanta 23
Brussels 23
Johannesburg 23
Changsha 22
Hyderabad 22
Norwalk 22
Detroit 21
Shanghai 21
Shenyang 21
Toronto 21
Brooklyn 20
Montreal 20
San Francisco 20
Denver 19
Zhengzhou 19
Amsterdam 18
Chennai 18
Guangzhou 18
Haiphong 18
Bareggio 17
Hebei 17
Jiaxing 17
Belo Horizonte 15
Brasília 15
Cambridge 15
Curitiba 15
Tashkent 15
Kraków 14
Nairobi 14
Totale 9.568
Salva come PNG Salva come JPEG
Nome #
The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitus. 340
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment 335
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 334
The Type 2b P.R1306w Natural Mutation Of Von Willebrand Factor Dramatically Enhances The Multimer Sensitivity To Shear Stress 314
Pathogenesis Of Portal Vein Thrombosis In Liver Cirrhosis: The Role of the ADAMTS13/VWF Unbalance 294
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 231
Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice. 194
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 193
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 191
Kinetic study of von Willebrand factor self-aggregation induced by ristocetin 184
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 179
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 174
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 173
β2-Glycoprotein I Binds Thrombin and Selectively Inhibits the Enzyme Procoagulant Functions 168
Effect of fibrinogen concentration on the velocity of platelet aggregation. 167
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13. A new prothrombotic mechanism associated with oxidative stress 166
The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study 158
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 158
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 157
Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study 155
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle 154
Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells 154
Congenital prothrombin deficiency: an update 154
Oxidized von Willebrand factor is efficiently cleaved by serine proteases from primary granules of leukocytes: divergence from adamts-13 151
An old drug for a new application: carbazochrome-sodium-sulfonate in HHT 149
Evaluation of the thiobarbituric acid test (TBA test) properties for the determination of glycosylated hemoglobins by comparison with chromatography and isoelectrofocusing. 147
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 145
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 143
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects 143
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 142
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation 142
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 141
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY 140
Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. 140
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects. 137
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 137
Diagnosis and management of cerebral venous sinus thrombosis in children: a single-center retrospective analysis 137
PURIFICATION OF THE ISOLATED BETA-CHAIN OF ADULT HUMAN-HEMOGLOBIN FROM ITS POST-TRANSLATIONAL MODIFICATION 136
Immune toilerance by intermittent factor VIII boluses in two hemophilia A patients 135
From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19 135
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 134
Hemophilia A and von Willebrand deficiency: therapeutic implications 131
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 131
Aims: The ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation (ORIGAMI) study investigates the safety and efficacy of Edoxaban administered via PEG in patients with atrial fibrillation and a clinical indication for a long-term anticoagulation. Design: In this prospective, single-centre observational study, 12 PEG-treated patients with indication to anticoagulation will receive edoxaban via PEG and will be followed up to 6 months. Plasma antifactor Xa activity and edoxaban concentrations will be assessed. Thromboembolic (ischaemic stroke, systemic embolism, venous thromboembolism) and bleeding events (Bleeding Academic Research Consortium and Thrombolysis in Myocardial Infarction) will be recorded at 1 and 6 months. Preliminary results: A retrospective analysis of five atrial fibrillation cases undergoing PEG implantation at our Institution who received edoxaban via PEG showed plasma anti-FXa levels at a steady state of 146 ± 15 ng/ml, without major adverse event at a mean follow-up of 6 months. Conclusion: ORIGAMI prospectively investigates PEG-administration of edoxaban in PEG-treated patients requiring long-term anticoagulation. Our preliminary retrospective data support this route of DOAC administration. 131
high performance liquid chromatography in protein sequence determination. 130
Hexopeptidase high performance liquid chromatography (HPLC) mapping and is application to peptide sequence strategies. 128
Ristocetin-induced self-aggregation of von Willebrand factor. 127
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 124
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 123
Proteolytic Processing of Von Willebrand Factor by Adamts13 and Leukocyte Proteases 123
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 123
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 122
Mechanochemistry of von Willebrand factor 121
SPONTANEOUS DEEP HEMATOMAS IN 2 PATIENTS WITH MYELOFIBROSIS - EVIDENCE OF PLATELET MEMBRANE GLYCOPROTEIN MODIFICATIONS 120
β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions 120
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 119
Another family with IGPS 119
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 118
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism 118
Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors 118
Effects of coagulation factors on bone cells and consequences of their absence in haemophilia a patients 117
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 116
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 116
Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features 115
Homocysteinemia is inversely correlated with platelet count and inversely correlated with sE-and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase 115
Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies. 115
The effect of shear stress on protein conformation: Physical forces operating on biochemical systems: The case of von Willebrand factor. 115
Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study 114
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 113
The dominant-negative von Willebrand factor gene deletion p.P1127_C1948delinsR: molecular mechanism and modulation. 113
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 113
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 113
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 113
Design organization and clinical processes around patient characteristics: Evidence from a multiple case study of Hemophilia 111
Oral Squamous Cell Carcinoma-Associated Thrombosis: What Evidence? 111
Congenital prothrombin deficiency 110
Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA 110
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study 110
Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure 108
Extended coagulation profile of children with Long Covid: a prospective study 107
Measurement of extended half-life recombinant FVIII molecules: In vitro and ex vivo evidence of relevant assay discrepancies 107
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey 107
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 107
Relevance of chloride binding to von Willebrand factor in type 2B von Willebrand disease patients 106
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects 106
Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy 105
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 104
Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini‐Delphi Consensus 102
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms 101
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 101
KINETIC ASPECTS OF RELEASE OF FIBRINOPEPTIDES AP AND AY BY HUMAN ALPHA-THROMBIN 100
Wiskott-Aldrich syndrome: report of an autosomal dominant variant 100
Placental-derived PGI2 inhibits cord blood platelet function 99
Placental derived PGI2 inhibits cord platelet function:possible role of PGI in THR transient hyporeactivity of newborn platelets 99
Mechanistic studies on ADAMTS13 catalysis. 99
Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy 99
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin 98
Measurement of plasma fibrinogen concentration by the prothrombin-time-derived method: applicability and limitations. 98
Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study 97
Apixaban Interacts with Haemoglobin: Effects on Its Plasma Levels 97
Totale 13.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.041 0 114 24 62 64 35 34 173 60 54 206 215
2022/20231.973 264 318 165 259 155 233 80 171 230 26 56 16
2023/20241.163 41 316 30 78 49 203 66 61 17 39 102 161
2024/20252.597 58 42 197 98 191 89 59 121 419 317 554 452
2025/20267.167 1.071 306 452 718 1.068 352 1.286 357 443 567 304 243
2026/2027637 228 409 0 0 0 0 0 0 0 0 0 0
Totale 18.856